Gujarat Kidney appoints Paresh Dhoti as Non-Executive Non-Independent Director

1 min read     Updated on 21 Jul 2026, 06:51 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Gujarat Kidney and Super Speciality Ltd appointed Mr Paresh Dhoti as an Additional Non-Executive Non-Independent Director on July 9, 2026, due to a technical issue with his independent director registration. The company will consider him for the Independent Director role in a future board meeting.

powered bylight_fuzz_icon
46185691

*this image is generated using AI for illustrative purposes only.

Gujarat Kidney and Super Speciality Ltd appointed Mr Paresh Dhoti as an Additional Non-Executive Non-Independent Director on July 9, 2026. The appointment was necessitated by a technical glitch that prevented the completion of his registration as an Independent Director with the Indian Institute of Corporate Affairs (IICA). The company stated that the registration process has since been completed successfully, and the Board will consider appointing him as a Non-Executive Independent Director in a subsequent meeting.

The clarification was submitted to BSE Limited and National Stock Exchange of India Limited regarding the outcome of the Board Meeting held on July 9, 2026. The disclosure was made under Regulation 30(6) read with Para A (7) of Part-A of Schedule III of the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/CFD/CFD PoD1/P/CIR/2023/123 dated July 13, 2023.

Mr Paresh Dhoti obtained a Bachelor of Dentistry in 2006 from Government Medical College, Ahmedabad. He has been practicing independently as a Dentist in Vadodara for the past 18 years. The company confirmed that Mr Dhoti is not related to any Director of the company.

Appointment Details

Particulars Description
Reason for change Appointment as an Additional Non-Executive Non Independent Director
Date of appointment 09.07.2026
Brief profile Bachelor of Dentistry (2006), Government Medical College, Ahmedabad; practicing independently in Vadodara for 18 years
Disclosure of relationships Not related to any Director of the Company

Historical Stock Returns for Gujarat Kidney and Super Speciality

1 Day5 Days1 Month6 Months1 Year5 Years
+0.71%-0.45%+0.75%+29.03%+22.63%+22.63%

What specific strategic value will Mr. Dhoti's medical background bring to the Board of a kidney care and super-specialty hospital company?

How will the Board structure evolve once Mr. Dhoti transitions from a Non-Independent to an Independent Director role?

Is the company anticipating any further governance or compliance changes following the resolution of the IICA registration issue?

Gujarat Kidney and Super Speciality
View Company Insights
View All News
like18
dislike

Gujarat Kidney acquires 51% stake in Blue Tree Clinics LLC, UAE

2 min read     Updated on 13 Jul 2026, 04:51 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Gujarat Kidney and Super Speciality Limited approved acquiring a 51% stake in Blue Tree Clinics LLC, UAE, for ₹19,83,64,500. The Board also appointed Mr. Paresh Dhoti as an Additional Independent Director and approved a postal ballot for IPO object variation.

powered bylight_fuzz_icon
45160549

*this image is generated using AI for illustrative purposes only.

Gujarat Kidney and Super Speciality Limited announced on July 9, 2026, that its Board of Directors has approved the acquisition of a 51% majority stake in Blue Tree Clinics LLC, a polyclinic licensed in Dubai, United Arab Emirates. The transaction, valued at ₹19,83,64,500, will be executed through a Share Purchase Agreement with consideration paid in two tranches over a maximum period of 50 days. This strategic move marks the company's expansion into international healthcare operations, specifically into a new geography and a set of services not currently provided in India.

Acquisition of Blue Tree Clinics LLC

Blue Tree Clinics LLC, incorporated on February 27, 2012, operates in the Medical Services sector. The entity is engaged in Plastic Surgery, Laser Cosmetic, General Dental Clinic, and Chiropractic Centre services. The target entity currently has three shareholders, with one holding 91.866% and two holding 8.114% of the equity. The acquisition is not a related party transaction, and no promoter, promoter group, or group companies hold any interest in the entity being acquired.

The following table summarises the key details of the acquisition:

Parameter: Details
Target Entity: Blue Tree Clinics LLC
Country of Incorporation & Operations: UAE (Dubai)
Date of Incorporation: February 27, 2012
Industry: Medical Services
Stake Acquired: 51%
Cost of Acquisition: ₹19,83,64,500/-
Nature of Consideration: Cash
Payment Structure: 2 tranches, maximum 50 days
Regulatory Approvals Required: None
Related Party Transaction: Not Applicable

Blue Tree Clinics LLC — Financial Performance

The target entity reported a Gross Revenue of 10,538,978 AED and a Net Profit of 31,38,809 AED during FY 2025. The company's revenue trend over the last three fiscal years is presented below:

Fiscal Year: Gross Revenue (AED)
FY 2023: 11,249,500
FY 2024: 9,068,150
FY 2025: 10,538,978

Board Appointment — Additional Independent Director

The Board approved the appointment of Mr. Paresh Dhoti (DIN: 11802188) as an Additional Non-Executive Independent Director, not liable to retire by rotation, with effect from July 9, 2026. The appointment is for a first term of five consecutive years, subject to approval by the members of the company at the next Annual General Meeting.

Key details of the appointment are as follows:

Parameter: Details
Name: Mr. Paresh Dhoti
DIN: 11802188
Designation: Additional Non-Executive Independent Director
Effective Date: July 9, 2026
Term: Five consecutive years (first term)
Relationship with Other Directors: Not related to any Director of the Company

Mr. Paresh Dhoti obtained his Bachelor of Dentistry in 2006 from Government Medical College, Ahmedabad, and has been practicing independently as a Dentist in Vadodara for the last 18 years.

Postal Ballot for IPO Object Variation

The Board also resolved to conduct a postal ballot seeking shareholder approval by way of Special Resolution for a Variation in Objects of the IPO. A separate intimation regarding the postal ballot will be filed in due course. The Board meeting commenced at 4:30 P.M. and concluded at 8:00 P.M. on July 9, 2026.

Historical Stock Returns for Gujarat Kidney and Super Speciality

1 Day5 Days1 Month6 Months1 Year5 Years
+0.71%-0.45%+0.75%+29.03%+22.63%+22.63%

How does Gujarat Kidney plan to integrate the aesthetic and dental services of Blue Tree Clinics into its existing core healthcare model?

What specific growth strategies does the company intend to pursue to reverse the revenue volatility observed at Blue Tree Clinics over the past three years?

Will the company utilize this acquisition framework to pursue further expansion into other Middle Eastern markets or medical specialties?

Gujarat Kidney and Super Speciality
View Company Insights
View All News
like15
dislike

More News on Gujarat Kidney and Super Speciality

1 Year Returns:+22.63%